![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| PIONEER 6.pdf | 2025-02-05 15:24 | 227K | |
| review of oral glp-1.pdf | 2025-02-05 15:24 | 326K | |
| PIONEER 5.pdf | 2025-02-05 15:24 | 461K | |
| PIONEER 4.pdf | 2025-02-05 15:24 | 509K | |
| IGNITE study.pdf | 2025-02-05 15:24 | 573K | |
| PIONEER 3.pdf | 2025-02-05 15:24 | 581K | |
| UPPER GI DISEASE AND ORAL SEMA.pdf | 2025-02-05 15:24 | 726K | |
| SOUL Baseline.pdf | 2025-02-05 15:24 | 807K | |
| PIONEER 7.pdf | 2025-02-05 15:24 | 899K | |
| PIONEER 1.pdf | 2025-02-05 15:24 | 969K | |
| oral sema meta analysis.pdf | 2025-02-05 15:24 | 1.0M | |
| PIONEER 2.pdf | 2025-02-05 15:24 | 1.1M | |
| PIONEER 8.pdf | 2025-02-05 15:24 | 1.2M | |
| SAFETY OF SEMAGLUTIDE.pdf | 2025-02-05 15:24 | 1.2M | |
| Efficacy of oral sema regardless of background medication.pdf | 2025-02-05 15:23 | 1.7M | |
| Managing GI side effects.pdf | 2025-02-05 15:24 | 1.8M | |
| GLP-1RAs - Beyond pancreatic effects.pdf | 2025-02-05 15:24 | 2.3M | |
| Buckley et al transcellular bsorption of oral semaglutide.pdf | 2025-02-05 15:24 | 7.7M | |